A Way To Reverse CAD
A Way To Reverse CAD
A Way To Reverse CAD
Esselstyn Jr,
MD; Gina Gendy, MD;
Jonathan Doyle, MCS;
Mladen Golubic, MD,
PhD; Michael F. Roizen,
MD
The Wellness Institute
of the Cleveland Clinic,
Lyndhurst, Ohio
[email protected]
The authors reported no
potential conflict of interest
relevant to this article.
Original Research
ABSTRACT
Purposeu Plant-based
nutrition achieved
coronary artery disease (CAD) arrest and reversal in a small study. However, there was
skepticism that this approach could succeed in
a larger group of patients. The purpose of our
follow-up study was to define the degree of
adherence and outcomes of 198 consecutive
patient volunteers who received counseling
to convert from a usual diet to plant-based
nutrition.
Methodsu We followed 198 consecutive
patients counseled in plant-based nutrition.
These patients with established cardiovascular
disease (CVD) were interested in transitioning
to plant-based nutrition as an adjunct to usual
cardiovascular care. We considered participants adherent if they eliminated dairy, fish,
and meat, and added oil.
Resultsu Of the 198 patients with CVD,
177 (89%) were adherent. Major cardiac
events judged to be recurrent disease totaled
one stroke in the adherent cardiovascular
participantsa recurrent event rate of .6%,
significantly less than reported by other studies of plant-based nutrition therapy. Thirteen
of 21 (62%) nonadherent participants experienced adverse events.
Conclusionu Most of the volunteer patients
with CVD responded to intensive counseling,
and those who sustained plant-based nutrition for a mean of 3.7 years experienced a
low rate of subsequent cardiac events. This dietary approach to treatment deserves a wider
356
n a 1985 program initiated at the Cleveland Clinic, we examined whether plantbased nutrition could arrest or reverse
advanced coronary artery disease (CAD) in
22 patients.1 One patient with restricted myocardial blood flow documented by positron
emission tomography (PET) showed reperfusion on a repeat scan just 3 weeks after starting our nutritional intervention (FIGURE 1 ).2
Within 10 months of the start of treatment,
another patient with severe right calf claudication and a quantifiably diminished pulse
volume experienced total pain relief and exhibited a measurably increased pulse volume
amplitude.2 Thus encouraged, we followed
the small cohort of patients (adding cholesterol-lowering drugs in 1987) and reported
results after 5 and 12 years of follow-up.1,3 Of
the 22 patients, 17 were adherent to the protocol, and their disease progression halted.
In 4 of the 12, we angiographically confirmed
disease reversal,4 which can be striking
(FIGURE 2 ).4
zThe significance of these findings.
CAD remains the number one killer of women and men in western civilization despite
40 years of aggressive drug and surgical interventions.5 These approaches can be lifesaving
in the midst of a heart attack. However, the
FIGURE 1
FIGURE 2
Restoration of myocardial
perfusion2
Reversal of coronary
artery disease4
Figure 1 from: PREVENT AND REVERSE HEART DISEASE by Caldwell B. Esselstyn, Jr., M.D., copyright 2007
by Caldwell B. Esselstyn, Jr., M.D. Used with permission of Avery Publishing, an imprint of Penguin
Group (USA) LLC.
Before Rx
After Rx
Positron emission tomography performed on a
patient with coronary artery disease shows an area
of myocardium with insufficient blood flow (top).
Following only 3 weeks of plant-based nutritional
intervention, normal blood flow was restored (bottom).
elective use of percutaneous coronary intervention (PCI) shows little protection from
future heart attacks or prolongation of life,6
perhaps because it does not treat the major
cause of this disease. Such palliative treatments also carry significant risk of morbidity and mortality and lead to unsustainable
expense.7
zGetting at the root cause of CAD requires a different approach. CAD begins
jfponline.com
METHODS
Participants
This report reviews the outcomes of 198 consecutive nonsmoking patients with multiple
comorbidities of hyperlipidemia (n=161), hypertension (n=60), and diabetes (n=23) who
voluntarily asked for counseling in plant-
357
358
Intervention
We explained to each participant that plantbased nutrition typically succeeded in arrestingand sometimes reversingCAD in our
earlier study.
zThe core diet. Whole grains, legumes,
lentils, other vegetables, and fruit comprised
the major portion of the diet. We reassured
patients that balanced and varied plantbased nutrition would cover their needs for
amino acids, and we encouraged them to
take a multivitamin and vitamin B12 supplement. We also advised the use of flax seed
meal, which served as an additional source
of omega-6 and omega-3 essential fatty acids.
zFoods prohibited. Initially the intervention avoided all added oils and processed
foods that contain oils, fish, meat, fowl, dairy
products, avocado, nuts, and excess salt. Patients were also asked to avoid sugary foods
(sucrose, fructose, and drinks containing
them, refined carbohydrates, fruit juices, syrups, and molasses). Subsequently, we also
excluded caffeine and fructose.
Exercise was encouraged but not required. The plan also did not require the practice of meditation, relaxation, yoga, or other
psychosocial support approaches. Patients
continued to use cardiac medications as prescribed, monitored by their (other) physicians.
zPre-intervention training. Each participant attended a single-day 5-hour coun-
TABLE 1
198
Men, N (%)
180 (91)
Age, mean SD
62.9 10.0
44.2 24.1
177 (89)
195 (98)
Angiography/CT angiography
180
Stress test
74
Myocardial infarction
44
CAD, coronary artery disease; CT, computed tomography; SD, standard deviation.
* Three patients had documented peripheral artery disease or cerebral or carotid vascular stenosis, but no CAD.
Many patients had more than one test done to establish the diagnosis of CAD.
RESULTS
Characteristics of participants
Baseline characteristics of participants are
shown in TABLE 1 . (Two patients from the
original group of 200 were lost to follow-up.)
The remaining 198 participants for whom
data were available had CVD, were mostly
men (91%), averaged 62.9 years of age, and
were followed for an average of 44.2 months
(3.7 years).
Three patients had noncoronary vascular disease: 1 cerebral vascular disease,
1 carotid artery disease, and 1 peripheral arterial disease. In the remaining 195 patients, angiogram results confirmed the diagnosis of CAD
in 180 (92%). With the other 15 participants,
electrocardiography, failed stress tests, or a history of enzyme-documented MI confirmed the
diagnosis of CAD. Of the 195-patient cohort,
44 (23%) had an MI prior to counseling.
Outcomes for nonadherent
CVD participants
Twenty-one patients (11%) were nonadher-
c o nti n u ed
jfponline.com
359
Only 1 major
cardiovascular
event (stroke)
was related
to disease
progression
in patients
adherent with
the dietary
intervention.
Also, 9 CAD patients required vascular intervention: 1 CABG for disease progression,
1 CABG for malpositioned dissecting stents
placed just prior to enrollment into the program, 1 stenting procedure and 2 CABGs
before valve repair, 2 stenting procedures to
correct grafted artery closing, and 2 CABGs
for asymptomatic patients persuaded of the
need by their primary caregivers. Two patients experienced a nonfatal stroke (one
after refusing warfarin for atrial fibrillation,
the second because of progression of CVD,
and one had stent thrombosis with acute MI
after discontinuing clopidogrel as advised by
the primary care physician. One patient had
3 stents placed before entering our study;
1 occluded at 3 years into the study, necessitating restenting (TABLE 2 ).
Thus, only 1 major cardiovascular event
(stroke) was related to disease progression
in patients adherent with the dietary intervention. This is a recurrent event rate of
0.6%. Thus, 99.4% of adherent patients avoided major cardiac events. This result clearly
contrasts with that of other key peer-reviewed
studies of nutrition interventions for patients
with CAD6,17-22 (TABLE W3 at www.jfponline.
com), although the disease burden and the
presence of comorbid conditions may not be
comparable. Even if all events had been attributable to diet, the 10% (18/177) event rate
(Worse group in TABLE 2 ) over an average of
3.7 years is much below that reported in the
literature23 and the 62% of the nonadherent
group.
DISCUSSION
This program of treating the presumed cause
of CAD has yielded significant findings and
raised practice implications. First, and quite
compelling, is that 89% of patients were willing to make a substantial lifestyle transition
to plant-based nutrition and sustain it for
an average of 3.7 years (for some patients
up to 13 years). Most participants saw this
as taking control of their disease (anecdotal
reports).
Second, the results of this evaluation
provide further evidence that plant-based
nutrition may prevent, halt, and reverse CAD.
This process of halting and reversing CAD
360
prospective cohort studies have recently emphasized the importance of nutrition in decreasing the risk of recurrent CVD events in
people with CVD or diabetes and decreasing
the risk of developing CVD among healthy
individuals. Dehghan and colleagues27 followed 31,546 participants with CVD or diabetes over 4.5 years and divided them into
quintiles of nutritional quality. Reduction in
CVD-related risk within the healthiest quintile was 35% for death, 14% for MI, and 19%
for stroke. They found this protective association was maintained whether or not patients
were receiving medications.
Crowe and colleagues28 followed
44,561 men and women enrolled in the European Prospective Investigation into Cancer
and Nutrition. Thirty-four percent (15,151)
were vegetarians, consuming neither meat
nor fish. During an 11.6-year follow-up, they
found vegetarians had a lower mean body
mass index, lower non-HDL-C level, lower
systolic blood pressure, and a 32% lower risk
of developing ischemic heart disease.28 These
combined studies of 76,107 individuals support an assertion of the power of nutrition for
primary and secondary prevention of cardiovascular illness.
By way of contrast are findings associated with a typical western diet. Wilkins and
colleagues29 assessed lifetime risk and years
lived free of total CVD by reviewing data from
905,115 person-years from 1964 to 2008. They
assessed risk factor presence and subsequent CVD. While lifetime risk estimates for
total CVD for all individuals was >30%, the
study found that even those men and women
55 years of age with optimal risk factors had a
40% and 30% likelihood of total CVD, respectively, by age 85. It would appear that even
optimal risk factors are no guarantee that the
TABLE 2
Adherent patients
Nonadherent patients
177 (89)
21 (11)
164 (93)
16 (76)
63.0 10.1
62.3 9.0
144 (81)
0 (0)
105 (94)
0 (0)
Outcomes
Improved
Symptom reduction
Reversal
39 (22)
Stable
15 (8)
8 (38)
Worse
18 (10)
13 (62)
Disease progression
Stroke
CABG
Restenting
Death
11
2
Stroke
CABG
Heart transplant
Noncardiac**
Cardiac
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CVD, cardiovascular disease; LIMA, left internal mammary artery; MI, myocardial infarction;
PAD, peripheral arterial disease; PCI, percutaneous coronary intervention; PCP, primary care physician; SD, standard deviation.
* Data missing for 5 adherent patients and 1 nonadherent patient.
Percentage of 112 patients who complained of angina at the start of intervention.
One patient with atrial fibrillation had documented angiographic reversal after 5 years in the study, then refused warfarin 2 years after last angiogram and
suffered a nonfatal stroke.
Adherent patients experienced worse outcomes significantly less frequently than nonadherent patients (P<.001, by Fishers exact test).
One patient enrolled into the program with malpositioned dissecting stents that required CABG.
# Before study enrollment, the patient had 3 stents placed; one occluded at 3 years in the study and was restented.
** Includes 3 cancer-related deaths, 1 fatal pulmonary embolism, and 1 case of pneumonia.
jfponline.com
361
For adherent
participants, the
adverse event
rate was, at
most, 10%.
362
explain why plant-based nutrition is so effective, yet we can postulate likely mechanisms.
When foods that injure or cause endothelium
dysfunction are avoided, the body readily
restores the capacity of endothelial tissue to
produce nitric oxide. Such change reduces
production of vasoconstricting endothelin
and thromboxane by injured endothelial
cells.
Our insistence on daily ingestion of generous portions of green leafy vegetables favors an improved population of endothelial
progenitor cells.33 Moreover, reductions in
lipid, homocysteine, and triglyceride levels
and insulin resistance enhance dimethylarginine dimethylaminohydrolase to enzymatically reduce asymmetric dimethylarginine
and optimize nitric oxide synthase availability in nitric oxide production. The blood
level of HDL-C may decrease with this antiinflammatory, plant-based nutrition. Nevertheless, the efflux capacity of HDL-C may be
unrelated to blood concentration and could
be significantly enhanced by the intervention to enable disease arrest or reversal.34,35
Consumers of plant-based nutrition do not
harbor the intestinal flora unique to om-
disease initiation and progression, these interventions do not address disease causation.
Not surprisingly, most patients experience
disease progression, more drugs, more imaging, repeat interventions, progressive disability, and, too often, death from a disease of
western malnutrition, the cause of which has
been largely left untreated. We have in press
several patient experiences that exemplify
the repeated failure of present-day cardiac
drugs and procedural interventions, and that
confirm the capacity of whole-food plantbased nutrition to restore health in there is
nothing further we can do situations.36
In summary, the present cardiovascular
medicine approach tested beyond 40 years
can neither cure the disease nor end the epidemic and is financially unsustainable. The
safety, diminished expense, and prompt,
powerful, and persistent results in treating
the cause of vascular disease by whole-food
plant-based nutrition offer a paradigm shift
from existing practice. We think the time is
right for a controlled trial. But in the meantime, the data are sound and strong enough
that patients should be informed of this
option.
JFP
The present
cardiovascular
medicine
approach can
neither cure the
disease nor end
the epidemic
and is financially
unsustainable.
Correspondence
References
1. Esselstyn CB Jr, Ellis SG, Medendorp SV, et al. A strategy to arrest
and reverse coronary artery disease: a 5-year longitudinal study
of a single physicians practice. J Fam Pract. 1995;41:560-568.
3. Esselstyn CB Jr. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for
palliative cardiology). Am J Cardiol. 1999;84:339-341,A8.
10. Vogel RA, Coretti MC, Plotnich GD. Effect of a single high-fat
meal on endothelial function in healthy subjects. Am J Cardiol.
1997;79:350-354.
11. Marchesi S, Lupattelli G, Schillaci G, et al. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men.
Atherosclerosis. 2000;153:397-402.
5. Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
Executive summary: heart disease and stroke statistics2012 update: a report from the American Heart Association. Circulation.
2012;125:188-197.
6. Boden WE, ORourke RA, Teo KK, et al; COURAGE Trial Research
Group. Optimal medical therapy with or without PCI for stable
coronary disease. N Engl J Med. 2007;356:1503-1516.
7. Trogdon JG, Finkelstein EA, Nwaise IA, et al. The economic burden of chronic cardiovascular disease for major insurers. Health
Promot Pract. 2007;8:234-242.
12. Bae JH, Bassenge E, Kim KB, et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress.
Atherosclerosis. 2001;155:517-523.
13. Campbell TC, Campbell TM II. Broken hearts. In: Campbell TC,
Campbell TM II. The China Study. Dallas, TX: BenBella Books;
2006:111-134.
14. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent
of atherosclerosis in adolescents and young adults: implications
for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281:727-735.
c o nti n u ed
jfponline.com
363
16. Esselstyn CB Jr. Is the present therapy for coronary artery disease
the radical mastectomy of the twenty-first century? Am J Cardiol.
2010;106:902-904.
17. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA.
1998;280:2001-2007.
18. Ornish D. Avoiding revascularization with lifestyle changes:
The Multicenter Lifestyle Demonstration Project. Am J Cardiol.
1998;82:72T-76T.
19. de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications
after myocardial infarction: final report of the Lyon Diet Heart
Study. Circulation. 1999;99:779-785.
20. Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk
patients (Indo-Mediterranean Diet Heart Study): a randomised
single-blind trial. Lancet. 2002;360:1455-1461.
21. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish,
and fibre intakes on death and myocardial reinfarction: diet and
reinfarction trial (DART). Lancet. 1989;2:757-761.
22. Kappagoda CT, Ma A, Cort DA, et al. Cardiac event rate in a lifestyle modification program for patients with chronic coronary
artery disease. Clin Cardiol. 2006;29:317-321.
23. Stone GW, Maehara A, Lansky AJ, et al; PROSPECT Investigators.
A prospective natural-history study of coronary atherosclerosis.
N Engl J Med. 2011;364:226-235.
24. Campbell TC, Parpia B, Chen J. Diet, lifestyle, and the etiology of
coronary artery disease: the Cornell China study. Am J Cardiol.
1998;82:18T-21T.
25. Sinnett PF, Whyte HM. Epidemiological studies in a total
highland population, Tukisenta, New Guinea. Cardiovascular disease and relevant clinical, electrocardiographic, radiological and biochemical findings. J Chronic Dis. 1973;26:
265-290.
26. Connor WE, Cerqueira MT, Connor RW, et al. The plasma lipids,
28. Crowe FL, Appleby PN, Travis RC, et al. Risk of hospitalization or
death from ischemic heart disease among British vegetarians and
nonvegetarians: results from the EPIC-Oxford cohort study. Am J
Clin Nutr. 2013;97:597-603.
29. Wilkins JT, Ning H, Berry J, et al. Lifetime risk and years lived free
of total cardiovascular disease. JAMA. 2012;308:1795-1801.
30. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J
Med. 2013;368:1575-1584.
31. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576-585.
32. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of
phosphatidylcholine promotes cardiovascular disease. Nature.
2011;472:57-63.
33. Mano R, Ishida A, Ohya Y, et al. Dietary intervention with Okinawan vegetables increased circulating endothelial progenitor
cells in healthy young women. Atherosclerosis. 2009;204:544-548.
34. Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux
capacity, high-density lipoprotein function, and atherosclerosis.
N Engl J Med. 2011;364:127-135.
35. Navab M, Reddy ST, Van Lenten BJ, et al. HDL and cardiovascular
disease: atherogenic and atheroprotective mechanisms. Nat Rev
Cardiol. 2011;8:222-232.
36. Esselstyn CB Jr, Golubic M. The nutritional reversal of cardiovascular diseasefact or fiction? J Exp Clin Cardiol. In press.
NEW
WEEkly QuizzEs!
364
www.jfponline.com/md-iq-quizzes.html
TABLE W3
Population
Dietary intervention
Outcomes
Significance of changes
Advice or no advice
(controls) on 3 dietary
factors: reduced fat,
increased fish, increased
fiber
No significant
differences in incidence
of reinfarction plus
cardiac death by any of
the dietary regimens
Randomized, 2 yrs
Ornish D et al, The
Lifestyle Heart Trial,
199817
48 patients with
moderate to severe
CAD
Randomized, 5 yrs
28
20
Ornish D et al,
Multicenter Lifestyle
Demonstration Project,
199818
No significant difference
in cardiac events per
patient-year of follow up
Average savings in
avoiding
revascularization,
$29,529/patient
Nonrandomized, 3 yrs
194
31 patients
underwent PTCA and
26 had CABG
139
66 patients
underwent PTCA and
73 underwent CABG
423 consecutive
patients who survived
a first MI
Composite outcome
of MI + CVD death
219
Experimental group
followed Mediterranean
diet
1.24
204
4.07
Singh RB et al,
Indo-Mediterranean Diet
Heart Study, 200220
Randomized, 2 yrs
Total cardiac
endpoints (nonfatal
MI + fatal MI + sudden
cardiac death)
499
39
501
76
c o ntin u e d
jfponline.com
364a
TABLE W3
134 consecutive
patients with
angiographically
confirmed CAD
77
1.5%
P<.02
57
Nonadherent patients
18%
Boden WE et al,
COURAGE Study, 20076
Cumulative primary
event (composite of
death from any cause
and nonfatal MI) rates
1138
19.5%
No significant
difference in recurrent
major cardiac events
1149
20%
198 consecutive
patients with CAD
Dietary intervention vs
nonadherent patients,
3.7 yrs
177
Adherent patients
followed a vegan diet
with 10% of calories from
fat and no added oil
2.2%
21
Nonadherent
62%
P<.001
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CI, confidence interval; CVD, cardiovascular disease; MI, myocardial infarction; NCEP, National
Cholesterol Education Program; PCI, percutaneous coronary intervention; PTCA, percutaneous transluminal coronary angioplasty.
* Patients in the experimental group also participated in exercise, stress management, and support group.
Per 100 patients per year of follow-up.
In both groups 2/3 of patients were vegetarians.
364b